亚临床设备检测心房颤动与卒中风险的系统综述与荟萃分析
该系统综述与荟萃分析纳入11项研究,评估心脏植入电子设备(CIED)检测到的亚临床心房颤动(AF)与卒中风险的关系。结果显示,亚临床AF在起搏适应症患者中发生率约35%,与临床AF强相关(OR 5.7),且超过定义阈值的亚临床AF患者年卒中率为1.89/100人年,风险较未超过阈值者增加2.4倍。
要点
- 亚临床AF在CIED患者中常见,发生率为35%(IQR 34-42)。
- 亚临床AF与临床AF强相关(OR 5.7, 95%CI 4.0-8.0)。
- 超过阈值的亚临床AF年卒中率1.89/100人年,风险增加2.4倍。
核心结论
- 亚临床AF强烈预测临床AF,并与绝对卒中风险升高相关,但风险低于临床AF所描述的风险。
研究设计与样本
- 系统综述与荟萃分析,检索Pubmed/Embase,最终纳入11项报告CIED患者亚临床AF与卒中关系的研究。
主要发现
- 亚临床AF在起搏适应症患者中发生率35%(IQR 34-42),随访1-2.5年。
- 亚临床AF与临床AF相关(OR 5.7, 95%CI 4.0-8.0, P<0.001, I2=0%)。
- 超过定义阈值的亚临床AF年卒中率1.89/100人年(95%CI 1.02-3.52),较未超过阈值者风险增加2.4倍(95%CI 1.8-3.3, P<0.001, I2=0%),后者绝对风险0.93/100人年。
- 平均CHADS2评分2.1±0.1的研究中,亚临床AF相关年卒中率2.76/100人年(95%CI 1.46-5.23)。
- 排除无AF患者后,仅17%的卒中发生在AF持续存在时;29%(IQR 8-57)的卒中前30天内发现亚临床AF。
关键数值与推荐
- 亚临床AF的定义和卒中风险截断时长在各研究间存在差异。
临床怎么用
- CIED检测到的亚临床AF应视为临床AF和卒中风险的重要预警信号,需个体化评估抗凝策略。
局限性
- 亚临床AF的定义和截断时长异质性较大,可能影响卒中风险估计的准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To determine stroke risk in subclinical atrial fibrillation (AF) and temporal association between subclinical AF and stroke. METHODS AND RESULTS: Pubmed/Embase was searched for studies reporting stroke in subclinical AF in patients with cardiac implantable electronic devices (CIEDs). After exclusions, 11 studies were analysed. Of these seven studies reported prevalence of subclinical AF, two studies reported association between subclinical and clinical AF, seven studies reported stroke risk in subclinical AF, and five studies reported temporal relationship between subclinical AF and stroke. Subclinical AF was noted after CIEDs implant in 35% [interquartile range (IQR) 34-42] of unselected patients with pacing indication over 1-2.5 years. The definition and cut-off duration (for stroke risk) of subclinical AF varied across studies. Subclinical AF was strongly associated with clinical AF (OR 5.7, 95% CI 4.0-8.0, P < 0.001, I2 = 0%). The annual stroke rate in patients with subclinical AF > defined cut-off duration was 1.89/100 person-year (95% CI 1.02-3.52) with 2.4-fold (95% CI 1.8-3.3, P < 0.001, I2 = 0%) increased risk of stroke as compared to patients with subclinical AF < cut-off duration (absolute risk was 0.93/100 person-year). Three studies provided mean CHADS2 score. In these studies, with mean CHADS2 score of 2.1 ± 0.1, subclinical AF was associated with annual stroke rate of 2.76/100 person-years (95% CI 1.46-5.23). After excluding patients without AF, only 17% strokes occurred in presence of ongoing AF. Subclinical AF was noted in 29% [IQR 8-57] within 30 days preceding stroke. CONCLUSION: Subclinical AF strongly predicts clinical AF and is associated with elevated absolute stroke risk albeit lower than risk described for clinical AF.
引用
- Mahajan R, Perera T, Elliott AD, et al. Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis. Eur Heart J. 2018. PMID: 29340587. doi:10.1093/eurheartj/ehx731
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。